Previous Section Index Home Page

4 Mar 2010 : Column 1394W—continued


Sports: Primary Education

Michael Gove: To ask the Secretary of State for Children, Schools and Families what estimate he has made of the number of (a) comprehensive and (b) maintained primary schools which held a school sports day in the latest period for which figures are available. [315705]

Mr. Iain Wright: The annual PE and Sport survey collects data from maintained schools relating to pupils' participation in PE and sport. The 2008/09 survey found that all primary schools and 98 per cent. of secondary schools held a sports day during the last academic year.

Health

Abortion

Anne Milton: To ask the Secretary of State for Health pursuant to the answer of 3 February 2010, Official Report, columns 382-3W, on abortion, what the evidential basis is for the statement that additional funding for contraception in the last two years has contributed to a decrease in abortion rates. [319957]

Gillian Merron: The Department invested additional funds in contraception services in April 2008 (£12.8 million), September 2008 (£10 million) and April 2009 (£11.6 million). In each of the last five quarters (July 2008 to September 2009), the abortion rate was lower than the corresponding quarter in the preceding year. As these decreases in the abortion rate coincide with the period in which the additional investment was available, we believe that the additional investment, and other measures we have taken, has made a contribution towards the decreases in the abortion rate.

Aortic Aneurysm: Screening

Mr. Spring: To ask the Secretary of State for Health (1) how much the NHS Abdominal Aortic Screening programme has cost to date; [320049]

(2) how many phases of NHS Abdominal Aortic Screening programme there will be; [320050]

(3) which NHS trusts have submitted an application to the NHS Abdominal Aortic Screening programme to begin an ultrasound screening programme for aortic aneurysms; [320051]

(4) what the timetable is for the full implementation of the NHS Abdominal Aortic Screening programme; [320052]

(5) what estimate his Department made about the number of patients who will have been screened in each of the sites covered by phase one of the NHS Abdominal Aortic Screening programme after (a) one year and (b) five years; [320054]

(6) when ultrasound screening for aortic aneurysms will begin in each of the sites covered by phase one of the NHS Abdominal Aortic Screening programme; [320055]

(7) what steps his Department is taking to ensure that men aged 65 years old participate in an ultrasound screening programme for aortic aneurysms (a) at each of the early implementation sites and (b) when the programme is fully implemented. [320056]


4 Mar 2010 : Column 1395W

Ann Keen: The NHS Abdominal Aortic Aneurysm screening programme has cost £5,335,809.50 up to the end of March 2010. This is made up of start up and full year costs for six early implementation sites, start up costs for four phase one sites, screening equipment for 10 sites, training of technicians and information leaflets.

It is anticipated that there will be a maximum of eight phases of roll out, however the exact number is unknown
4 Mar 2010 : Column 1396W
as this depends on the number of applications received and geographical fit of each local screening programme.

The following national health service trusts have been successful with their applications to begin ultrasound screening for aortic aneurysms:

Phase Screening Programme NHS Trust

Early Implementation

Gloucestershire

Gloucestershire Hospitals NHS Foundation Trust

Early Implementation

West Sussex

Royal West Sussex NHS Trust

Early Implementation

South West London

St George's Healthcare Trust

Early Implementation

South Devon and Exeter

South Devon Healthcare NHS Foundation Trust

Early Implementation

South Manchester

Central Manchester and Manchester Children's University Hospital NHS Foundation Trust

Early Implementation

Leicestershire

University Hospitals of Leicester NHS Trust

Phase 1

Peninsula

Royal Cornwall Hospitals NHS Trust Plymouth Hospitals NHS Trust

Phase 1

Heartlands

Heart of England NHS Foundation Trust

Phase 1

South East London

Guy's and St Thomas' Hospital NHS Trust

Phase 1

North East

Gateshead Health NHS Foundation Trust

Phase 1

North Central London

The Royal Free Hampstead NHS Trust

Phase 1

North West London

Imperial Healthcare NHS Trust

Phase 1

East Yorkshire and The Humber

Hull and East Yorkshire Hospital NHS Trust


It is anticipated that full national roll out of the Abdominal Aortic Aneurysm screening programme will be completed by the end of 2012-13.

The following table details the numbers of patients screened in phase one after a) one

year and b) five years:

Screening Programme Year One Year Five

Peninsula

4,369

29,512

South East London

4,818

32,548

North East

11,598

78,350

Heartlands

3,364

22,721

North Central London

3,966

26,789

North West London

7,349

49,648

East Yorkshire and The Humber

4,199

28,363


All phase one sites will be screening by the end of May 2010.

The national programme team have put in place a number of measures to ensure the highest possible take up of screening once men have been identified for screening through their general practitioner. Examples include:

Mr. Spring: To ask the Secretary of State for Health how many patients have been screened as part of the NHS Abdominal Aortic Screening programme at each early implementation site. [320053]

Ann Keen: The following table details the number of patients screened by each screening programme to the end of February 2010:

Screening Programme Numbers of patients screened

Gloucestershire

4,214

Leicestershire

4,247

South West London

3,000

South Devon

2,276

South Manchester

1,878

West Sussex

3,111


Basildon and Thurrock University Hospitals NHS Foundation Trust

Andrew Mackinlay: To ask the Secretary of State for Health what recent assessment has been made of the standard and quality of care and management at Basildon and Thurrock Hospital Trust by (a) Monitor, (b) the Care Quality Commission and (c) his Department. [320267]

Mr. Mike O'Brien: Chris Mellor, Acting Chair of Monitor, the regulatory body for NHS Foundation Trusts, has written to my right hon. Friend the Secretary of State about the progress being made at the trust.


4 Mar 2010 : Column 1397W

Monitor has advised that further progress has been made at the trust since December 2009.

The Care Quality Commission (CQC) has advised that it has an ongoing engagement with Basildon and Thurrock as part of the registration process which began in January. CQC is in the process of assessing whether conditions will need to be attached to the trust's registration on 1 April.

The Secretary of State will update the House in a written ministerial statement which will be issued on 5 March.

Bone Marrow Disorders: Drugs

Mr. Willis: To ask the Secretary of State for Health (1) whether the drug Peginterferon alfa-2a has been approved by the National Institute for Health and Clinical Excellence for use with patients with essential thrombocythaemia; [320596]

(2) which primary care trusts in (a) London and (b) the South East have approved the funding for the treatment of essential thrombocythaemia with Peginterferon alfa-2a. [320597]

Mr. Mike O'Brien: Peginterferon alfa-2a is not licensed for the treatment of essential thrombocythaemia and the National Institute for Health and Clinical Excellence has not been asked to appraise it for this condition.

Information on primary care trusts' funding decisions is not collected centrally.

Colorectal Cancer: Screening

Mr. Evans: To ask the Secretary of State for Health what steps his Department is taking to increase the levels of participation in bowel cancer screening programmes. [320339]

Ann Keen: Primary care trusts (PCTs) are responsible for screening services, including the promotion of the national health service bowel screening programme. We would expect those areas with low bowel screening uptake rates to develop targeted programmes to tackle this locally.

As the bowel cancer screening programme was implemented in local areas, NHS Cancer Screening Programmes sent out an information pack to all local general practitioners (GPs). As well as explaining how the programme works, the packs contained promotional information, including posters for GPs to use to promote the programme in their own practices.

The National Awareness and Early Diagnosis Initiative, launched in November 2008, is working with NHS Cancer Screening Programmes on key messages and awareness programmes to improve screening uptake, particularly in deprived groups.

Complementary Medicine

Mr. Willis: To ask the Secretary of State for Health what complementary or alternative treatments, medicines or therapies are offered through the National Health Service; and what evidence his Department has considered on the efficacy of each. [320578]


4 Mar 2010 : Column 1398W

Gillian Merron: The commissioning and funding of any treatments, including complementary/alternative, is the responsibility of the national health service. Many strategic health authorities and primary care trusts have developed their own policies on which treatments they will provide based one the safety and clinical and cost-effectiveness of a treatment as well as the availability of suitably qualified/regulated practitioners. When developing guidance for the management of health conditions, the National Institute for Health and Clinical Excellence (NICE) considers complementary therapies, where appropriate and sufficient evidence of effectiveness exists, alongside conventional treatments.

Dementia

Mr. Stephen O'Brien: To ask the Secretary of State for Health (1) how many staff in a (a) elderly mentally infirm and (b) standard care home are required to have a qualification in dementia awareness; [319959]

(2) Health what recent estimate he has made of the (a) length of stay in care homes of residents with dementia and (b) proportion of residents in care homes with a diagnosis of dementia. [319960]

Phil Hope: The Care Homes Regulations 2001 - Regulation 18 - require homes to

This will include ensuring that there are suitable numbers of staff trained and able to care for residents with dementia.

We are informed by the NHS Information Centre that data on the length of stay in care homes of residents with dementia and the proportion of residents in care homes with a diagnosis of dementia are not collected centrally.

The Care Quality Commission (CQC) registers care homes under the Care Standards Act 2000 (CSA), which remains operational until 30 September 2010. The CSA makes no provision for a registration category of "elderly mentally infirm". Homes are registered with CQC as care homes or care homes with nursing.

Subject to the approval of Parliament, care homes will be registered from 1 October 2010 under the 'regulated activity' in which they are engaged - that is, 'accommodation for persons who require nursing or personal care'. It will be for CQC to decide whether to record detailed information for each care home, such as whether it provides care for people with dementia.


Next Section Index Home Page